Milnacipran for the management of fibromyalgia syndrome
Michelle J Ormseth, Anne E Eyler, Cara L Hammonds, Chad S BoomershineDivision of Rheumatology and Immunology, Vanderbilt University, Nashville, TN, USAAbstract: Fibromyalgia syndrome (FMS) is a widespread pain condition associated with fatigue, cognitive dysfunction, sleep disturbance, depression, a...
Main Authors: | Michelle J Ormseth, Anne E Eyler, Cara L Hammonds, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | Journal of Pain Research |
Online Access: | http://www.dovepress.com/milnacipran-for-the-management-of-fibromyalgia-syndrome-a4020 |
Similar Items
-
Role and rationale for the use of milnacipran in the management of fibromyalgia
by: Jay D Kranzler, et al.
Published: (2010-04-01) -
Effect of milnacipran on body weight in patients with fibromyalgia
by: Arnold LM, et al.
Published: (2012-10-01) -
Duloxetine for the management of fibromyalgia syndrome
by: Beth A Scholz, et al.
Published: (2009-07-01) -
Comparison Analysis between the Medication Efficacy of the Milnacipran and Functional Connectivity of Neural Networks in Fibromyalgia Patients
by: Seong-Ho Kim, et al.
Published: (2020-05-01) -
Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study
by: Bateman L, et al.
Published: (2013-04-01)